Neumora Therapeutics Stock Jumps, Analyst Sees Upside In Alzheimer's Treatment

William Blair upgrades Neumora after strong Alzheimer's agitation data, sees upside from NMRA-511 and obesity pipeline potential.

Read Full Article →